Skip to main content
International Journal of Preventive Medicine logoLink to International Journal of Preventive Medicine
editorial
. 2020 Jun 19;11:74. doi: 10.4103/ijpvm.IJPVM_199_20

Why Children are Less Likely to Contract COVID-19 Infection than Adults?

Farahnak Assadi 1,
PMCID: PMC7373085  PMID: 32742618

The novel coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[1] The reported cases of COVID-19 among children have been less severe than those in adults.[2] Dong et al.,[3] in a recent clinical study of more than 2000 infants and preschool-aged children with suspected COVID-19, found that 4% of virologically confirmed cases were symptomatic and among children who were symptomatic, 5% experienced dyspnea and hypoxemia, and only 0.6% progressed to acute respiratory distress syndrome, a substantially lower percentage rate than has been reported in adults.

The findings of children that are less likely than adults to become severely ill from COVID-19 are challenging to discern.[4]

Previous data from clinical trials suggest that children and adults who are healthy have a balanced renin-angiotensin system (RAS)––both the angiotensin-converting enzyme (ACE)/angiotensin II and angiotensin-converting enzyme 2 (ACE2)/angiotensin (1–7) pathways.[5,6] However, as we age and/or develop disease (hypertension, chronic kidney disease, diabetes, cardiovascular disease), we have relatively more ACE/angiotensin II compared to ACE2/angiotensin (1–7).[7,8] The ACE2 pathway increases to compensate, but only to a point, at which time the ACE pathway is essentially unopposed.[9,10]

Remember ACE2 degrades angiotensin II (“bad”) into angiotensin (1–7) (“good”).

We definitely have data that this shift in the RAS occurs more in children than in adults with hypertension, chronic kidney disease, and cardiovascular disease.[11]

In COVID-19, the hypothesis is that children have plenty of ACE2 but it easily counteracts the ACE pathway. Thus, children have the same (or higher) risk of infection with SARS-CoV-2, but are protected (in part) from the (likely) angiotensin II-mediated acute lung (and possibly heart/kidney/brain) injury that we see in COVID-19.

For sure, there are many other factors, which may play major role in the pathogenesis of COVID-19 disease. This is just one theory that could be involved.

References

  • 1.CoronavirIdae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCov and naming it SARS-Cov-2. Nat Microbiol. 2020;5:536–44. doi: 10.1038/s41564-020-0695-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cruz AT, Zeichner SL. COVID-19 in children: Initial characterization of the pediatric disease. Pediatrics. 2020;145:e20200834. doi: 10.1542/peds.2020-0834. [DOI] [PubMed] [Google Scholar]
  • 3.Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China? Pediatrics. 2020;145:e20200702. doi: 10.1542/peds.2020-0702. doi: 10.1542/peds.2020-0702. [DOI] [PubMed] [Google Scholar]
  • 4.Jenco M. COVID-19 less severe in children than adults: Study. AAP News Content Editor. 2020. Available from: http://wwwaappublicationsorg/ne ws/2020/01/28/coronavirus .
  • 5.Ferrario CM. ACE2: More of Ang-(1-7) or less Ang II? Curr Opin Nephrol Hypertens. 2011;20:1–6. doi: 10.1097/MNH.0b013e3283406f57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Varagic J, Ahmad S, Ferrario CM. ACE2: Angiotensin II/Angiotensin-(1-7) balance in cardiac and renal injury. Curr Hypetens Rep. 2014;16:420. doi: 10.1007/s11906-014-0420-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Souza Dos Santo RA, Passaglio KT, Pesquero JB, Bader M, Simoes E, Silva AC. Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels. Hypertension. 2001;38:660–4. doi: 10.1161/01.hyp.38.3.660. [DOI] [PubMed] [Google Scholar]
  • 8.Chappell MC, Allred AJ, Ferrario CM. Pathways of angiotensin-(1-7) mechanism in the kidney. Nephrol Dial Transplant. 2001;16:22–6. doi: 10.1093/ndt/16.suppl_1.22. [DOI] [PubMed] [Google Scholar]
  • 9.Santos RAS, Ferreira AJ, Simoes e Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin-(-7) Mas axis. Exp Physiol. 2008;93:519–27. doi: 10.1113/expphysiol.2008.042002. [DOI] [PubMed] [Google Scholar]
  • 10.Brant Pinheiro SV, Simons e AC. Angiotensin converting emzyme 2, angiotensin-(1-7), and receptor Mas axis in the kidney. Int J Hpertens. 2012:414128. doi: 10.1155/2012/414128. doi: 101155/2012/414128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fernandez-Atucha A, Izagirre A, Fraile-Bermudez AB, Kortajarena M, Larrinaga G, Martinez-Lage P, et al. Sex differences in the aging pattern of renin-angiotensin system serum peptidases. Biol Sex Differ. 2017;8:5. doi: 10.1186/s13293-017-0128-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Preventive Medicine are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES